• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺导管内乳头状黏液性肿瘤切除术后复发:单中心复发预测因素研究。

Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.

机构信息

Hepato-Biliary and Pancreatic Surgery Unit, Edouard Herriot Hospital-HCL, Lyon, France.

出版信息

Pancreas. 2012 Jan;41(1):137-41. doi: 10.1097/MPA.0b013e318222bc9c.

DOI:10.1097/MPA.0b013e318222bc9c
PMID:22076564
Abstract

OBJECTIVE

The detection of intraductal papillary mucinous neoplasms (IPMN) has increased over the last decade, but still, management remains controversial. The main problems are their potential for malignancy and risk of recurrence. The purpose of this study was to determine the predictive factors of recurrence after surgical resection.

METHODS

All patients with IPMN who underwent pancreatectomy with curative intent were considered. Data were collected from a prospective base.

RESULTS

From 1994 to 2009, 104 patients underwent pancreatectomy. Twenty-one (20%) had recurrence, 15 on remnant pancreas (none on pancreatic cut surface) and 6 with distant metastases. Twelve patients had total pancreatectomy (1 awaiting surgery). Thirteen (38.2%) of 34 patients with invasive IPMN and 20 (25.9%) of 77 with main duct involvement (including combined type) had recurrence. In univariate analysis, American Society of Anesthesiologist score and histological and duct type had a significant impact on recurrence rate. In multivariate analysis, histological type (invasiveness) was the only significant predictive factor for recurrence.

CONCLUSION

The risk of recurrence of IPMN after resection depends on the histological type. According to surgical margin, invasiveness, and the type of duct involved, we identified a high-risk group with invasive main duct lesion and a low-risk group with noninvasive branch duct lesion.

摘要

目的

在过去的十年中,人们对胰管内乳头状黏液性肿瘤(IPMN)的检出率有所增加,但治疗方法仍存在争议。主要问题是其恶性潜能和复发风险。本研究旨在确定手术切除后复发的预测因素。

方法

所有接受根治性胰切除术的 IPMN 患者均被纳入研究。数据来自一个前瞻性数据库。

结果

1994 年至 2009 年,104 例患者接受了胰切除术。21 例(20%)患者出现复发,其中 15 例在残胰(胰腺切面上无),6 例发生远处转移。12 例患者行全胰切除术(1 例等待手术)。34 例侵袭性 IPMN 患者中有 13 例(38.2%)和 77 例主胰管受累(包括混合型)患者中有 20 例(25.9%)出现复发。单因素分析显示,美国麻醉医师协会评分、组织学和胰管类型对复发率有显著影响。多因素分析显示,组织学类型(侵袭性)是复发的唯一显著预测因素。

结论

切除后 IPMN 的复发风险取决于组织学类型。根据手术切缘、侵袭性和受累胰管类型,我们确定了一个高危组,即具有侵袭性主胰管病变,和一个低危组,即具有非侵袭性分支胰管病变。

相似文献

1
Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.胰腺导管内乳头状黏液性肿瘤切除术后复发:单中心复发预测因素研究。
Pancreas. 2012 Jan;41(1):137-41. doi: 10.1097/MPA.0b013e318222bc9c.
2
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.208例胰腺导管内乳头状黏液性肿瘤切除术的经验。
Arch Surg. 2008 Jul;143(7):639-46; discussion 646. doi: 10.1001/archsurg.143.7.639.
3
Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.胰腺导管内乳头状黏液性肿瘤行胰十二指肠切除术后的结局:一项机构经验
Surgery. 2007 Oct;142(4):529-34; discussion 534-7. doi: 10.1016/j.surg.2007.07.007.
4
A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.一项关于胰腺分支导管内乳头状黏液性肿瘤手术切除后复发的大型多中心研究。
Minerva Gastroenterol Dietol. 2017 Mar;63(1):50-54. doi: 10.23736/S1121-421X.16.02341-2. Epub 2016 Nov 8.
5
Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.胰腺内导管乳头状黏液性肿瘤中胰腺切缘状态的预后影响。
Surgery. 2010 Aug;148(2):285-90. doi: 10.1016/j.surg.2010.03.013.
6
Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.胰腺导管内乳头状黏液性肿瘤:浸润及胰腺切缘状态对复发和生存的影响
Ann Surg Oncol. 2006 Apr;13(4):582-94. doi: 10.1245/ASO.2006.05.002. Epub 2006 Mar 7.
7
Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.胰腺非侵袭性和微创性导管内乳头状黏液性肿瘤的手术结果
Ann Surg Oncol. 2006 Jul;13(7):955-60. doi: 10.1245/ASO.2006.05.043. Epub 2006 May 18.
8
Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.胰腺导管内乳头状黏液性肿瘤手术切除后的结果。
Am J Gastroenterol. 2000 Feb;95(2):441-5. doi: 10.1111/j.1572-0241.2000.01764.x.
9
Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.胰腺导管内乳头状黏液性肿瘤的手术结果
Ann Surg Oncol. 2007 Nov;14(11):3174-80. doi: 10.1245/s10434-007-9546-x. Epub 2007 Aug 12.
10
Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.胰腺导管内乳头状黏液性肿瘤患者行胰腺切除术后的长期前瞻性队列研究:对术后监测的意义
Ann Surg. 2014 Aug;260(2):356-63. doi: 10.1097/SLA.0000000000000470.

引用本文的文献

1
Recurrence following Resection of Intraductal Papillary Mucinous Neoplasms: A Systematic Review to Guide Surveillance.导管内乳头状黏液性肿瘤切除术后的复发:一项指导监测的系统评价
J Clin Med. 2024 Jan 31;13(3):830. doi: 10.3390/jcm13030830.
2
A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.一种新型的分期系统和临床预测列线图,用于更准确地分期和预测恶性胰腺导管内乳头状黏液性肿瘤的预后:一项基于人群的研究。
J Transl Med. 2021 Dec 24;19(1):525. doi: 10.1186/s12967-021-03188-4.
3
State-of-the-art surgical treatment of IPMNs.
胰管内乳头状黏液性肿瘤的最新外科治疗方法。
Langenbecks Arch Surg. 2021 Dec;406(8):2633-2642. doi: 10.1007/s00423-021-02349-9. Epub 2021 Nov 4.
4
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables.预防性全胰切除术在高危人群中的应用(PROPAN):使用决策表的系统评价和共享决策计划。
United European Gastroenterol J. 2020 Oct;8(8):865-877. doi: 10.1177/2050640620945534. Epub 2020 Jul 23.
5
Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).胱硫醚双加氧酶 1(CDO1)基因启动子 DNA 高甲基化在导管内乳头状黏液性肿瘤(IPMN)中。
Ann Surg Oncol. 2020 Oct;27(10):4007-4016. doi: 10.1245/s10434-020-08291-2. Epub 2020 Mar 6.
6
Subtype of intraductal papillary mucinous neoplasm of the pancreas is important to the development of metachronous high-risk lesions after pancreatectomy.胰腺导管内乳头状黏液性肿瘤的亚型对于胰腺切除术后异时性高危病变的发生发展至关重要。
Ann Hepatobiliary Pancreat Surg. 2019 Nov;23(4):365-371. doi: 10.14701/ahbps.2019.23.4.365. Epub 2019 Nov 29.
7
Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology.偶然发现的胰腺囊性病变的诊断和监测:2017 年韩国腹部放射学会共识建议。
Korean J Radiol. 2019 Apr;20(4):542-557. doi: 10.3348/kjr.2018.0640.
8
The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN.胰管内乳头状黏液性肿瘤行胰近端切除术(PPPD)后残胰远段胰管扩张的困境。
J Gastrointest Surg. 2019 Aug;23(8):1593-1603. doi: 10.1007/s11605-018-4026-0. Epub 2019 Jan 2.
9
Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study.手术切缘是否影响非浸润性导管内乳头状黏液性肿瘤的复发?:一项多机构研究。
Ann Surg. 2018 Sep;268(3):469-478. doi: 10.1097/SLA.0000000000002923.
10
ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts.ACG 临床指南:胰腺囊肿的诊断和管理。
Am J Gastroenterol. 2018 Apr;113(4):464-479. doi: 10.1038/ajg.2018.14. Epub 2018 Feb 27.